Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PEOPLE - Metasyn adds four executives to senior management team:

This article was originally published in Clinica

Executive Summary

Metasyn, a US imaging agent company, has recently added four executives to its senior management team. Dr Stanley Crooke, founder, chairman and CEO of Isis Pharmaceuticals, has joined Metasyn's board of directors, and is named chairman of its scientific advisory board. Dr James Smith becomes executive vice-president of development. He was formerly senior director of radiopharmaceutical R&D with DuPont Merck Pharmaceutical. Dr Kent Yucel is named senior vice-president and chief medical officer. Prior to this he was chief of vascular and interventional radiology and director of MRI at Boston University Medical Centre. Dr Stephen Knight is appointed vice-president of strategic planning and corporate development. He was previously a senior manager in the healthcare practice Arthur D Little.

You may also be interested in...

GT Medical Technologies Raised $16M In Funding To Expand Brain Tumor Therapy

The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.

AMS Acquires Raleigh Adhesive Coatings Company For £22M ($29M) In Cash

Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business. 

Amgen Hands Omecamtiv Back To Cytokinetics

While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts